BPC-157 5mg (10 Vials)

BPC – 157 Overview:

BPC-157 is a laboratory research material used in controlled experimental settings to investigate peptide behavior, signaling pathways, and model systems related to tissue and gastrointestinal biology. References to biological effects are provided for scientific context only and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit. This product is not offered for human or veterinary use.

Preclinical Research Context

Published laboratory studies have examined BPC-157 in experimental models involving peptide stability, cellular signaling, and tissue-associated pathways. Any findings described here are limited to research context and do not imply approved medical, veterinary, or consumer use.

BPC – 157: Structure

Source: pubchem

Sequence: GEPPPGKPADDAGLV

Molecular Formula: C₆₂H₉₈N₁₆O₂₂

Molecular Weight: ~1419.54 Da

PubChem CID: 9941957

Research Applications

BPC-157 may be used in laboratory studies involving:

• Peptide stability research

• Cellular signaling studies

• Gastrointestinal model systems

• Vascular signaling research

• Inflammatory marker analysis

• Structural biology investigations

All uses are limited to research settings only. This product is not intended for diagnosis treatment, prevention, or consumption.

Research Note

Any references to neurological or neurochemical pathways are included only to summarize scientific literature and are not claims of safety, efficacy, or suitability for human or animal use.

Scientific References

References to published literature are provided for educational purposes only. They do not constitute a claim that this product is approved, effective, or intended for human or animal use.

BPC – 157 : Scientific Journal & Authors

Predrag Sikirić, Professor at the University of Zagreb, has been a leading contributor to research on the stable gastric pentadecapeptide BPC-157. He is the primary author of “Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC-157: Vascular Recruitment and Gastrointestinal Tract Healing” and a co-author of “Stable Gastric Pentadecapeptide BPC-157 in Honeybee (Apis mellifera) Therapy to Control Nosema ceranae Invasions in Apiary Conditions.”

Referenced Citations

Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System

Predrag Sikiric 1, Sven Seiwerth 2, Anita Skrtic 2, Mario Staresinic 3, Sanja Strbe 1, Antonia Vuksic 1, Suncana Sikiric 2, Dinko Bekic 1, Dragan Soldo 1, Boris Grizelj 1, Luka Novosel 1 4, Lidija Beketic Oreskovic 1, Ivana Oreskovic 1, Mirjana Stupnisek 1, Alenka Boban Blagaic 1, Ivan Dobric 1 3

Józwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review. Pharmaceuticals (Basel). 2025 Jan 30;18(2):185. doi: 10.3390/ph18020185. PMID: 40005999; PMCID: PMC11859134.

ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.

The products available on this website are intended solely for in-vitro research purposes (Latin: “in glass”), meaning they are used in experiments conducted outside a living organism. These products are not medicines or drugs, have not been evaluated or approved by the U.S. Food and Drug Administration (FDA), and are not intended to diagnose, treat, cure, or prevent any disease or medical condition. Any administration to humans or animals, whether by ingestion, injection, or other means, is strictly prohibited by law.